We recently published a list of the 10 Best Strong Buy Stocks To Buy Right Now. In this article, we are going to take a look ...

The stock's rise snapped a four-day losing streak.

Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience. As of fiscal year-end 2024, Thermo ...

According to Benzinga Pro, Thermo Fisher Scientific's peer group average for short interest as a percentage of float is 6.24% ...

The Discovery Center has partnered with Thermo Fisher Scientific to launch a new exhibit called “The Lab” which teaches ...

The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9% ...

Shares of Thermo Fisher Scientific Inc. TMO slid 2.39% to $514.20 Tuesday, on what proved to be an all-around rough trading ...

Collegium Pharmaceutical is executing on commercializing its drugs and growing sales. Click here to find out why COLL stock ...

Explore Thermo Fisher's latest developments in transmission electron microscopy (TEM) technology, specifically focusing on ...

According to a comprehensive report from The Insight Partners, "Molecular Spectroscopy Market share and Forecasts 2022 - 2030, Global and Regional Share ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

The factors contributing to the growth of the microcarriers market are rising investments in cell & gene therapy research, ...